Annual report [Section 13 and 15(d), not S-K Item 405]

Stock-Based Compensation

v3.26.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

8. Stock-Based Compensation

 

2021 Incentive Plan

 

Our 2021 Equity Incentive Plan (the “2021 Plan”) authorizes the grant of stock options (incentive and non-statutory), stock appreciation rights and restricted stock covering a total of 3,166,667 shares of our common stock. Options are granted at the fair value of our common stock on the date of grant and generally vest either immediately or over a period of up to three years from the date of grant and expire 10 years from the date of grant. As of December 31, 2025, 1,076,332 shares were reserved for issuance related to the 2021 Plan and 2,090,335 shares of our common stock remain available for awards.

 

Recipients of stock awards under our 2021 Incentive Plan become the owner of record of the stock immediately upon grant, which may be subject to certain restrictions. The balance of unvested restricted stock will be forfeited and automatically transferred back to us at no cost upon the termination of the recipient’s employment. Upon vesting of restricted stock that is made to recipients who are employees, the recipient has the option to settle minimum withholding taxes by electing to have us withhold otherwise deliverable shares having a fair value equal to the required tax obligations (“net-settlement”). The net-settlement shares are then immediately cancelled and retired and reduce the shares available for issuance under the 2021 Incentive Plan.

 

We use the Black-Scholes option pricing model to estimate the fair value of stock-based awards on the date of grant. The assumptions employed in the calculation of the fair value of share-based compensation expense were calculated as follows for all years presented:

 

Expected dividend yield – zero based on the fact that we do not plan to issue dividends.
Expected volatility – based on our historical market price at consistent points in a period equal to the expected life of the options.
Risk-free interest rate – based on the U.S. Treasury yield curve in effect at the time of grant.
Expected life of options – based on the simplified method of estimating the expected life. Forfeitures are accounted for as they occur.

 

 

Assumptions used to estimate the fair value of stock options granted were as follows:

 

Granted in Period   High     Low     Weighted Average  
Award/Strike Price     1.03       0.86       0.93  
Market Price     0.93       0.86       0.92  
Volatility     117.87 %     117.79 %     117.87 %
Dividend Yield     0.00 %     0.00 %     0.00 %
Expected Life     6.00 yrs       5.00 yrs       5.25 yrs  
Risk Free Rate     3.82 %     3.72 %     3.74 %

 

Unrecognized Stock-Based Compensation Costs

 

Total stock-based compensation related to stock options was $555,747 and $516,049 for the years ended December 31, 2025, and 2024, respectively. As of December 31, 2025, there was $208,004 of unrecognized stock-based compensation related to stock options, which is expected to be recognized over a weighted average period of three years.

 

Stock Option Activity

 

Stock option activity for the year ended December 31, 2025, was as follows:

 

                Weighted
Average
       
          Weighted Average     Remaining
Contractual
    Aggregate  
    Number of
Shares
    Exercise
Price
    Term
(In Years)
    Intrinsic
Value(1)
 
Outstanding at December 31, 2024     33,150     $ 142.71       6.72     $  
Granted     1,052,320       0.93       5.25        
Forfeited     (9,138 )     105.90              
Outstanding at December 31, 2025     1,076,332       4.41       9.89     $  
Exercisable at December 31, 2025     812,332       5.54       9.87        

 

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our common stock as of December 31, 2025, and 2024, respectively

 

Certain other information regarding our stock-based awards was as follows:

 

    2025     2024  
Weighted average grant date fair value of stock options granted per share   $ 0.77     $ 11.46  
Grant date fair value of stock options that vested   $ 819,842     $ 305,632